IDEAS home Printed from https://ideas.repec.org/h/nbr/nberch/13991.html
   My bibliography  Save this book chapter

Economic Dimensions of Personalized and Precision Medicine in Asia: Evidence from Breast Cancer Treatment in Taiwan

In: Economic Dimensions of Personalized and Precision Medicine

Author

Listed:
  • Jui-fen Rachel Lu
  • Karen Eggleston
  • Joseph Tung-Chieh Chang

Abstract

No abstract is available for this item.

Suggested Citation

  • Jui-fen Rachel Lu & Karen Eggleston & Joseph Tung-Chieh Chang, 2018. "Economic Dimensions of Personalized and Precision Medicine in Asia: Evidence from Breast Cancer Treatment in Taiwan," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 237-272, National Bureau of Economic Research, Inc.
    • Handle: RePEc:nbr:nberch:13991
    as

    Download full text from publisher

    File URL: http://www.nber.org/chapters/c13991.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Mark V. Pauly, 2017. "Cost Sharing in Insurance Coverage for Precision Medicine," NBER Working Papers 24095, National Bureau of Economic Research, Inc.
    2. Liran Einav & Amy Finkelstein & Heidi Williams, 2016. "Paying on the Margin for Medical Care: Evidence from Breast Cancer Treatments," American Economic Journal: Economic Policy, American Economic Association, vol. 8(1), pages 52-79, February.
    3. Mark V. Pauly, 2018. "Cost Sharing in Insurance Coverage for Precision Medicine," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 159-184, National Bureau of Economic Research, Inc.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Mark Shepard & Katherine Baicker & Jonathan Skinner, 2020. "Does One Medicare Fit All? The Economics of Uniform Health Insurance Benefits," Tax Policy and the Economy, University of Chicago Press, vol. 34(1), pages 1-41.
    2. Damien Besancenot & Karine Lamiraud & Radu Vranceanu, 2023. "A model for dual health care market with congestion differentiation," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 32(2), pages 400-423, April.
    3. Atul Gupta & Sabrina T Howell & Constantine Yannelis & Abhinav Gupta, 2021. "Does Private Equity Investment in Healthcare Benefit Patients? Evidence from Nursing Homes," Working Papers 2021-20, Becker Friedman Institute for Research In Economics.
    4. Aljoscha Janssen, 2022. "Price dynamics of Swedish pharmaceuticals," Quantitative Marketing and Economics (QME), Springer, vol. 20(4), pages 313-351, December.
    5. Yoshida, Jun, 2021. "Does disclosure of success rates induce patients to move to a better clinic? Evidence from In Vitro Fertilization," MPRA Paper 108441, University Library of Munich, Germany.
    6. Sovinsky, Michelle & Stern, Steven & Michel, Chloé, 2019. "Value of Risky Lifestyle Choices," CEPR Discussion Papers 13537, C.E.P.R. Discussion Papers.
    7. Paul Dolfen & Liran Einav & Peter J. Klenow & Benjamin Klopack & Jonathan D. Levin & Larry Levin & Wayne Best, 2023. "Assessing the Gains from E-Commerce," American Economic Journal: Macroeconomics, American Economic Association, vol. 15(1), pages 342-370, January.
    8. David Card & Alessandra Fenizia & David Silver, 2018. "The Health Effects of Cesarean Delivery for Low-Risk First Births," NBER Working Papers 24493, National Bureau of Economic Research, Inc.
    9. Rositsa Koleva-Kolarova & James Buchanan & Heleen Vellekoop & Simone Huygens & Matthijs Versteegh & Maureen Rutten-van Mölken & László Szilberhorn & Tamás Zelei & Balázs Nagy & Sarah Wordsworth & Apos, 2022. "Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options," Applied Health Economics and Health Policy, Springer, vol. 20(4), pages 501-524, July.
    10. Kortelainen, Mika & Markkanen, Jaakko & Siikanen, Markku & Toivanen, Otto, 2023. "The Effects of Price Regulation on Pharmaceutical Expenditure and Availability," Working Papers 157, VATT Institute for Economic Research.
    11. Lucarelli, Claudio & Nicholson, Sean & Tilipman, Nicholas, 2022. "Price Indices and the Value of Innovation with Heterogenous Patients," Journal of Health Economics, Elsevier, vol. 84(C).

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nbr:nberch:13991. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: the person in charge (email available below). General contact details of provider: https://edirc.repec.org/data/nberrus.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.